Skip to main content
. 2022 Mar 9;22(5):728–750. doi: 10.17305/bjbms.2021.6888

FIGURE 13.

FIGURE 13

Clinical characteristics and immune characteristics in the validation cohort. (A) Compositional differences analysis of clinical traits between low- and high-risk subgroups; (B) comparison of TME components between low- and high-risk subgroups; (C) the landscape of the distribution of immune cell infiltration in the validation cohort; and (D) the expression levels of ICGs in the validation cohort.